
Jeffrey T. Palenik
Examiner (ID: 10079, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1154 |
| Issued Applications | 622 |
| Pending Applications | 123 |
| Abandoned Applications | 453 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4820683
[patent_doc_number] => 20080226713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Controlled Release Pharmaceutical Compositions of Tolperisone for Oral Administration'
[patent_app_type] => utility
[patent_app_number] => 10/591004
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5242
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591004 | Controlled Release Pharmaceutical Compositions of Tolperisone for Oral Administration | Mar 6, 2005 | Abandoned |
Array
(
[id] => 5666630
[patent_doc_number] => 20060171980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Implantable or insertable medical devices having optimal surface energy'
[patent_app_type] => utility
[patent_app_number] => 11/048147
[patent_app_country] => US
[patent_app_date] => 2005-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5449
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171980.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048147 | Implantable or insertable medical devices having optimal surface energy | Jan 31, 2005 | Abandoned |
Array
(
[id] => 6944367
[patent_doc_number] => 20050196416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Dispersions prepared by use of self-stabilizing agents'
[patent_app_type] => utility
[patent_app_number] => 11/043314
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5523
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196416.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043314 | Dispersions prepared by use of self-stabilizing agents | Jan 25, 2005 | Abandoned |
Array
(
[id] => 5182617
[patent_doc_number] => 20070053963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Drug delivery to a joint'
[patent_app_type] => utility
[patent_app_number] => 10/541808
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17419
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541808 | Drug delivery to a joint | Jan 12, 2005 | Abandoned |
Array
(
[id] => 6982879
[patent_doc_number] => 20050152949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Drug delivery to a joint'
[patent_app_type] => utility
[patent_app_number] => 11/035375
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17424
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035375 | Drug delivery to a joint | Jan 12, 2005 | Issued |
Array
(
[id] => 6938672
[patent_doc_number] => 20050112235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Multi component controlled release system for oral care, food products, nutraceutical, and beverages'
[patent_app_type] => utility
[patent_app_number] => 11/025256
[patent_app_country] => US
[patent_app_date] => 2004-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13507
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025256 | Multi component controlled release system for oral care, food products, nutraceutical, and beverages | Dec 28, 2004 | Abandoned |
Array
(
[id] => 6966088
[patent_doc_number] => 20050232985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Ciprofloxacin hcl'
[patent_app_type] => utility
[patent_app_number] => 10/519467
[patent_app_country] => US
[patent_app_date] => 2004-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2555
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519467 | Ciprofloxacin hcl | Dec 26, 2004 | Abandoned |
Array
(
[id] => 7074388
[patent_doc_number] => 20050147656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan'
[patent_app_type] => utility
[patent_app_number] => 11/020365
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18187
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020365 | Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan | Dec 22, 2004 | Abandoned |
Array
(
[id] => 5648340
[patent_doc_number] => 20060134072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Self-assembling protein matrix prepared from natural extracellular matrices'
[patent_app_type] => utility
[patent_app_number] => 11/022517
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8522
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022517 | Self-assembling protein matrix prepared from natural extracellular matrices | Dec 21, 2004 | Abandoned |
Array
(
[id] => 8896310
[patent_doc_number] => 08475831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Treatment of ophthalmic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/582728
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 11662
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10582728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582728 | Treatment of ophthalmic conditions | Dec 16, 2004 | Issued |
Array
(
[id] => 7038957
[patent_doc_number] => 20050158391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Azithromycin multiparticulate dosage forms by melt-congeal processes'
[patent_app_type] => utility
[patent_app_number] => 11/003856
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158391.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003856
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003856 | Azithromycin multiparticulate dosage forms by melt-congeal processes | Dec 2, 2004 | Abandoned |
Array
(
[id] => 6982912
[patent_doc_number] => 20050152982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Controlled release multiparticulates formed with dissolution enhancers'
[patent_app_type] => utility
[patent_app_number] => 11/003853
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18918
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003853 | Controlled release multiparticulates formed with dissolution enhancers | Dec 2, 2004 | Abandoned |
Array
(
[id] => 6905209
[patent_doc_number] => 20050100604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Production method for sustained-release preparation'
[patent_app_type] => utility
[patent_app_number] => 11/001889
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11023
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100604.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001889 | Production method for sustained-release preparation | Dec 1, 2004 | Abandoned |
Array
(
[id] => 7038822
[patent_doc_number] => 20050158256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Cosmetics tester and method of manufacturing such a tester'
[patent_app_type] => utility
[patent_app_number] => 11/001009
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2027
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158256.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001009 | Cosmetics tester and method of manufacturing such a tester | Dec 1, 2004 | Abandoned |
Array
(
[id] => 7112208
[patent_doc_number] => 20050209664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Electrical devices and anti-scarring agents'
[patent_app_type] => utility
[patent_app_number] => 10/998349
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 140794
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998349 | Electrical devices and anti-scarring agents | Nov 25, 2004 | Abandoned |
Array
(
[id] => 5224745
[patent_doc_number] => 20070254011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Bone Formation Agent and Method of Production'
[patent_app_type] => utility
[patent_app_number] => 10/580549
[patent_app_country] => US
[patent_app_date] => 2004-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6534
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580549 | Bioabsorbable composite material | Nov 24, 2004 | Issued |
Array
(
[id] => 6990539
[patent_doc_number] => 20050089576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Sustained release formulation of a peptide'
[patent_app_type] => utility
[patent_app_number] => 10/990033
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6684
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990033
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990033 | Sustained release formulation of a peptide | Nov 15, 2004 | Abandoned |
Array
(
[id] => 7773085
[patent_doc_number] => 08119161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Blister pack and solid dosage form therefor'
[patent_app_type] => utility
[patent_app_number] => 10/519715
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2390
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519715 | Blister pack and solid dosage form therefor | Nov 11, 2004 | Issued |
Array
(
[id] => 7098549
[patent_doc_number] => 20050131008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => '42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 10/987771
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14868
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987771 | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5865117
[patent_doc_number] => 20060099247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Liquid, gas and/or vapor phase delivery systems'
[patent_app_type] => utility
[patent_app_number] => 10/986101
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12798
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10986101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/986101 | Liquid, gas and/or vapor phase delivery systems | Nov 9, 2004 | Abandoned |